Public Profile

Abbott

Abbott Laboratories, commonly known as Abbott, is a leading global healthcare company headquartered in the United States. Founded in 1888, Abbott has established a strong presence in various operational regions, including North America, Europe, and Asia. The company operates primarily in the medical devices, diagnostics, nutrition, and pharmaceuticals sectors. Abbott is renowned for its innovative products, such as the FreeStyle Libre glucose monitoring system and Similac infant formula, which set industry standards for quality and effectiveness. With a commitment to advancing health and well-being, Abbott has achieved significant milestones, including the rapid development of COVID-19 testing solutions. As a market leader, Abbott consistently ranks among the top healthcare companies worldwide, recognised for its dedication to research and development, and its ability to deliver cutting-edge solutions that improve patient outcomes.

DitchCarbon Score

How does Abbott's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

64

Industry Average

Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

26

Industry Benchmark

Abbott's score of 64 is higher than 98% of the industry. This can give you a sense of how well the company is doing compared to its peers.

98%

Let us know if this data was useful to you

Abbott's reported carbon emissions

In 2023, Abbott reported significant carbon emissions across various regions, with total Scope 1 emissions amounting to approximately 207,000,000 kg CO2e in the US and 31,000,000 kg CO2e in the Netherlands. The company has set ambitious targets to reduce its absolute Scope 1 and 2 emissions by 30% by 2030, using 2018 as the baseline year. This commitment aligns with the Science Based Targets initiative (SBTi) and aims to contribute to limiting global warming to well below 2°C. Abbott's emissions reduction strategy includes operational energy efficiency, purchasing renewable energy, electrifying industrial processes, and integrating sustainable engineering technologies. The company also aims for 82% of its suppliers to have science-based targets by 2026, further enhancing its sustainability efforts. In addition to its near-term goals, Abbott has committed to achieving net-zero emissions by 2050, demonstrating a long-term commitment to environmental responsibility. The company’s proactive approach to reducing its carbon footprint reflects its dedication to sustainability within the healthcare sector.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

201020132014201520162017201820192020202120222023
Scope 1
620,000,000
000,000,000
000,000,000
000,000,000
000,000
000,000
000,000,000
000,000,000
000,000,000
000,000,000
0,000,000
0,000,000
Scope 2
648,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
Scope 3
-
-
-
-
-
-
-
0,000,000
0,000,000
-
0,000,000,000
0,000,000,000

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Abbott's primary industry is Medical, precision and optical instruments, watches and clocks (33), which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Abbott is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Abbott is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Novartis

CH
Pharmaceutical Preparation Manufacturing
Updated about 2 hours ago

Bayer

DE
Chemicals nec
Updated about 1 hour ago

Eli Lilly and Company

GB
Pharmaceutical Preparation Manufacturing
Updated 32 minutes ago

Sanofi

FR
Pharmaceutical Preparation Manufacturing
Updated about 19 hours ago

Mindray

CN
Medical, precision and optical instruments, watches and clocks (33)
Updated about 1 hour ago

Air France Klm

FR
Air transport services (62)
Updated about 13 hours ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers